Share This Page
Suppliers and packagers for QUELICIN PRESERVATIVE FREE
✉ Email this page to a colleague
QUELICIN PRESERVATIVE FREE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Hospira | QUELICIN PRESERVATIVE FREE | succinylcholine chloride | INJECTABLE;INJECTION | 008845 | NDA | Hospira, Inc. | 0409-6629-02 | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-6629-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-6629-12) | 2005-04-30 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: QUELICIN PRESERVATIVE FREE
Introduction
Quelicin Preservative Free, known generically as succinylcholine chloride, is a neuromuscular blocker used primarily for facilitating endotracheal intubation and muscle relaxation during surgical procedures. Its preservative-free formulation minimizes the risk of hypersensitivity reactions, making it suitable for patients with allergies to preservatives. The quality, reliability, and compliance of suppliers are crucial for healthcare providers and pharmaceutical manufacturers aiming to ensure safe, effective, and regulatory-compliant distribution of this medication.
Overview of Quelicin Preservative Free
Quelicin, a brand of succinylcholine chloride, is produced under stringent pharmaceutical standards. Its preservative-free formulation enhances patient safety, especially in sensitive populations such as neonates, immunocompromised individuals, or those with allergies. Due to the critical nature of neuromuscular blocking agents, manufacturers and suppliers must adhere to Good Manufacturing Practices (GMP), enforce strict quality controls, and maintain reliable distribution channels.
Global Suppliers of Quelicin Preservative Free
The market for succinylcholine chloride, especially preservative-free variants, is relatively consolidated, with a handful of global pharmaceutical companies authorized to produce and distribute this medication. The supply chain spans across regions including North America, Europe, and Asia. The primary suppliers include:
1. Hikma Pharmaceuticals
Overview: Hikma, a leading multinational pharmaceutical company headquartered in Jordan, manufactures and distributes a wide array of injectable medications, including neuromuscular blocking agents. Their manufacturing facilities adhere to globally recognized GMP standards, supplying preservative-free succinylcholine chloride.
Product Scope: Hikma offers preservative-free succinylcholine chloride in various vial sizes, emphasizing stability and sterility.
Distribution: Their global network allows supply to hospitals and distributors across the Middle East, Africa, Latin America, and parts of Europe and Asia.
2. Fresenius Kabi
Overview: Headquartered in Germany, Fresenius Kabi is renowned for its sterile drug manufacturing and infusion therapies. They produce succinylcholine chloride preservative-free formulations for clinical use.
Product Standards: Fresenius Kabi maintains rigorous quality controls, with products compliant with European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) standards.
Market Presence: Their distribution is extensive, serving North America, Europe, Asia, and other regions requiring high-quality sterile injectables.
3. Sandoz (Novartis)
Overview: Sandoz, a division of Novartis, specializes in generic pharmaceuticals, including neuromuscular blockers like succinylcholine chloride. They manufacture preservative-free formulations with a focus on stability and efficacy.
Regulatory Approvals: Their products are approved by major regulatory bodies, ensuring adherence to international standards.
Availability: Sandoz supplies to hospitals, clinics, and wholesale distributors globally, particularly in North America and Europe.
4. APP Pharmaceuticals (Part of Fresenius)
Overview: APP Pharmaceuticals, now integrated under Fresenius Kabi, previously specialized in sterile injectables.
Product Range: They produce preservative-free succinylcholine chloride, often described for their high purity and sterile manufacturing processes.
Distribution Network: Their products are widely available in North America and emerging markets.
5. Local and Regional Manufacturers
In addition to these global firms, certain regional manufacturers, especially in India and China, produce preservative-free succinylcholine chloride under strict regulatory oversight.
- Stephens India: Offers succinylcholine chloride preservative-free for regional distribution, adhering to Indian GMP standards.
- Qilu Pharmaceutical (China): Manufactures neuromuscular blocking agents, including preservative-free succinylcholine, meeting CFDA (China Food and Drug Administration) compliance.
Regulatory and Quality Considerations
Sourcing succinylcholine chloride preservative-free requires verification of regulatory compliance. Respecting local approval statuses, such as FDA approval in the United States, EMA approval in Europe, and other regional certifications, ensures product safety and efficacy. Suppliers should provide:
- Certificates of Analysis (CoA).
- GMP compliance documentation.
- Stability data for preservative-free formulations.
- Batch-specific quality control reports.
Supply Chain Risks and Considerations
Dependence on limited suppliers introduces risks such as supply disruptions, regulatory changes, or manufacturing issues. To mitigate these risks, procurement strategies should include:
- Engaging multiple qualified suppliers.
- Verifying supplier compliance and accreditation.
- Regularly auditing manufacturing facilities.
- Ensuring transparent communication channels.
Market Trends and Future Outlook
The demand for preservative-free neuromuscular blockers stems from increased safety awareness and regulatory push towards minimizing preservative-related adverse reactions. The global neuromuscular blocker market is expected to grow moderately, driven by expanding surgical procedures and critical care needs, thereby increasing the importance of reliable preservative-free succinylcholine chloride suppliers.
Key Potential Suppliers for Quelicin Preservative Free
| Supplier | Region | Notable Certifications | Distribution Focus | Remarks |
|---|---|---|---|---|
| Hikma Pharmaceuticals | Middle East, Africa, Latin America | GMP, ISO, FDA (varies) | Global | Widely trusted, ample manufacturing capacity |
| Fresenius Kabi | Europe, North America, Asia | EMA, FDA | Global | Known for high-quality sterile injectables |
| Sandoz (Novartis) | North America, Europe | GMP, FDA | Global | Extensive product portfolio, reputation for quality |
| APP Pharmaceuticals | North America | FDA, GMP | North America | Focus on sterile injectables |
| Local manufacturers (India, China) | Asia | CFR, GMP | Regional | Cost-effective, expanding global presence |
Conclusion
The procurement of Quelicin Preservative Free involves selecting well-regarded suppliers with rigorous quality standards, regulatory approval, and reliable distribution networks. Global leaders such as Hikma Pharmaceuticals, Fresenius Kabi, and Sandoz emerge as primary sources, supported by regional manufacturers capable of meeting regional demand. Ensuring product quality and regulatory compliance remains paramount to safeguard patient health, minimize liability, and optimize treatment outcomes.
Key Takeaways
- Reliable sourcing depends on global leaders with GMP compliance: Hikma, Fresenius Kabi, and Sandoz are primary suppliers.
- Regional manufacturers provide cost-effective options but require careful regulatory verification.
- Regulatory certifications (FDA, EMA) ensure product safety and legal compliance.
- Diversify supplier base to mitigate risks of supply chain disruptions.
- Continually monitor regulatory updates, especially around preservative-free formulations, to maintain compliance.
FAQs
1. What are the main advantages of preservative-free Quelicin (succinylcholine chloride)?
Preservative-free formulations reduce the risk of hypersensitivity reactions, making the drug safer for sensitive populations such as neonates, immunocompromised patients, and those with allergies to preservatives.
2. Which regions have the largest suppliers of preservative-free succinylcholine chloride?
Europe and North America feature the largest, most regulated manufacturers like Fresenius Kabi and Sandoz, with regional manufacturing hubs in Asia, notably India and China, supplying at more competitive costs.
3. How can healthcare providers ensure the authenticity and quality of succinylcholine chloride?
Request certificates of analysis, verify regulatory approvals, source from certified suppliers, and conduct periodic audits to confirm manufacturing compliance to GMP standards.
4. Are there any concerns about the stability of preservative-free succinylcholine chloride?
Yes, preservative-free formulations may have shorter shelf lives or stability concerns; thus, sourcing from reputable manufacturers that provide comprehensive stability data is critical.
5. What are the regulatory considerations when importing succinylcholine chloride?
Importers must ensure the product complies with regional licensing requirements, has approved regulatory documentation, and adheres to local pharmacovigilance standards.
Sources
[1] European Medicines Agency. "Summary of Product Characteristics: Succinylcholine." EMA, 2022.
[2] U.S. Food and Drug Administration. “Approved Drugs: Quelicin (succinylcholine chloride).” FDA, 2023.
[3] Hikma Pharmaceuticals. “Product Portfolio.” Hikma, 2022.
[4] Fresenius Kabi. “Injectable Medications.” Fresenius Kabi, 2022.
[5] Sandoz. “Geriatric and Critical Care Products.” Sandoz, 2023.
More… ↓
